Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

microRNA Regulation and Its Consequences in Cancer.

Parpart S, Wang XW.

Curr Pathobiol Rep. 2013 Mar;1(1):71-79. Epub 2012 Dec 18.

2.

dPORE-miRNA: polymorphic regulation of microRNA genes.

Schmeier S, Schaefer U, MacPherson CR, Bajic VB.

PLoS One. 2011 Feb 4;6(2):e16657. doi: 10.1371/journal.pone.0016657.

3.

MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways.

Davis-Dusenbery BN, Hata A.

Genes Cancer. 2010 Nov;1(11):1100-14. doi: 10.1177/1947601910396213.

4.

The complexities of microRNA regulation: mirandering around the rules.

Breving K, Esquela-Kerscher A.

Int J Biochem Cell Biol. 2010 Aug;42(8):1316-29. doi: 10.1016/j.biocel.2009.09.016. Epub 2009 Sep 30. Review.

PMID:
19800023
5.

Cross talk between microRNA and coding cancer genes.

Kunej T, Godnic I, Horvat S, Zorc M, Calin GA.

Cancer J. 2012 May-Jun;18(3):223-31. doi: 10.1097/PPO.0b013e318258b771. Review.

6.

Identification of common carp (Cyprinus carpio) microRNAs and microRNA-related SNPs.

Zhu YP, Xue W, Wang JT, Wan YM, Wang SL, Xu P, Zhang Y, Li JT, Sun XW.

BMC Genomics. 2012 Aug 21;13:413. doi: 10.1186/1471-2164-13-413.

7.

MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?

Karmon AE, Cardozo ER, Rueda BR, Styer AK.

Hum Reprod Update. 2014 Sep-Oct;20(5):670-87. doi: 10.1093/humupd/dmu017. Epub 2014 Apr 4. Review.

PMID:
24706045
8.

Exploring Mechanisms of MicroRNA Downregulation in Cancer.

Williams M, Cheng YY, Blenkiron C, Reid G.

Microrna. 2016 Dec 8. [Epub ahead of print]

PMID:
27928946
9.

MiRNA as potential biomarkers and therapeutic targets for gastric cancer.

Shin VY, Chu KM.

World J Gastroenterol. 2014 Aug 14;20(30):10432-9. doi: 10.3748/wjg.v20.i30.10432. Review.

10.

MicroRNA Polymorphisms in Cancer: A Literature Analysis.

Pipan V, Zorc M, Kunej T.

Cancers (Basel). 2015 Sep 9;7(3):1806-14. doi: 10.3390/cancers7030863.

11.

Single Nucleotide Polymorphisms Associated with MicroRNA Regulation.

Jin Y, Lee CG.

Biomolecules. 2013 Apr 9;3(2):287-302. doi: 10.3390/biom3020287.

12.

An unsolved mystery: the target-recognizing RNA species of microRNA genes.

Chen CZ.

Biochimie. 2013 Sep;95(9):1663-76. doi: 10.1016/j.biochi.2013.05.002. Epub 2013 May 14. Review.

13.

Inter- and intra-combinatorial regulation by transcription factors and microRNAs.

Zhou Y, Ferguson J, Chang JT, Kluger Y.

BMC Genomics. 2007 Oct 30;8:396.

15.

Principles of miRNA-mRNA interactions: beyond sequence complementarity.

Afonso-Grunz F, Müller S.

Cell Mol Life Sci. 2015 Aug;72(16):3127-41. doi: 10.1007/s00018-015-1922-2. Epub 2015 Jun 3. Review.

PMID:
26037721
16.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

17.

MicroRNAs, macrocontrol: regulation of miRNA processing.

Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A.

RNA. 2010 Jun;16(6):1087-95. doi: 10.1261/rna.1804410. Epub 2010 Apr 27.

18.

MiRNAs and miRNA Polymorphisms Modify Drug Response.

Li MP, Hu YD, Hu XL, Zhang YJ, Yang YL, Jiang C, Tang J, Chen XP.

Int J Environ Res Public Health. 2016 Nov 8;13(11). pii: E1096. Review.

19.

Non-coding RNAs for medical practice in oncology.

Setoyama T, Ling H, Natsugoe S, Calin GA.

Keio J Med. 2011;60(4):106-13. Review.

20.

Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.

Kaucsár T, Rácz Z, Hamar P.

Adv Drug Deliv Rev. 2010 Nov 30;62(14):1390-401. doi: 10.1016/j.addr.2010.10.003. Epub 2010 Oct 19. Review.

PMID:
20940025

Supplemental Content

Support Center